Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics

American Naturalist

Volumn 147, Issue 6, 1996, Pages 881-898

  Levin, Bruce R ^a   Bull, J J ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); BACTERIAL VIRUS; ESCHERICHIA COLI; MUS DOMESTICUS;

ANTIBIOTIC; POPULATION BIOLOGY;

EID: 0029661181     PISSN: 00030147     EISSN: None     Source Type: Journal    
DOI: 10.1086/285884     Document Type: Review

References (42)

1. Anderson, R. M., and R. May. 1991. Infectious disease of humans: dynamics and control. Oxford University Press, Oxford.
2. Antia, R., B. R. Levin, and R. M. May. 1994. Within-host population dynamics and the evolution and maintenance of microparasite virulence. American Naturalist 144:457-472.
3. Bloom, B. R., and J. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science (Washington, D.C.) 257:1055-1061.
4. Blyth, S. P., W. S. C. Gurney, P. Maas, and R. M. Nisbet. 1990. Solver: turbo Pascal program templates for integrated coupled sets of ordinary differential equations with possible delays and nonlinearities. University of Strathclyde, Glasgow.
5. Bonhoeffer, S., and M. Nowak. 1994. Mutation and the evolution of virulence. Philosophical Transactions of the Royal Society of London B, Biological Sciences 258:133-140.
6. Bull, J. J. 1994. Virulence. Evolution 48:1423-1437.
7. Burnet, F. M., M. McKie, and I. J. Wood. 1930. Infectigations on bacillary dysentery in infants, with special reference to the bacteriophage phenomena. Medical Journal of Australia 2:71-78.
8. Campbell, A. 1961. Conditions for the existence of bacteriophage. Evolution 15:153-165.
9. Chao, L., B. R. Levin, and F. M. Stewart. 1977. A complex community in a simple habitat: an experimental study with bacteria and phage. Ecology 58:369-378.
10. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a post-antibicrobial era. Science (Washington, D.C.) 257:1050-1055.
11. Cojocaru, L., and Z. Agur. 1992. Theoretical analysis of interval drug dosing for cell-cycle phase-specific drugs. Mathematical Biosciences 109:85-97.
12. Curry, S. H. 1980. Drug disposition and pharmacokinetics. 3d ed. Blackwell, Oxford.
13. Davies, J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science (Washington, D.C.) 264:375-382.
14. d'Herelle, F. 1926. The bacteriophage and its behavior. G. H. Smith, trans. Williams & Wilkins, Baltimore.
15. Dixon, B. 1987. Scientifically speaking. British Medical Journal 2:1168.
16. Dubos, R. J., J. H. Straus, and C. Pierce. 1943. The multiplication of bacteriophage in vivo and its protective effects against an experimental infection with Shigella dysenteriae. Journal of Experimental Medicine 78:161-168.
17. Eaton, M. D., and S. Bayne-Jones. 1934. Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. Journal of the American Medical Association 103:1769-1776, 1847-1853, 1934-1939.
18. Frieden, M. D., M. P. H. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine 328:521-526.
19. Frost, S. D., and A. R. McLean. 1994. Germinal center destruction as a major pathway of HIV pathogenesis. Journal of AIDS 7:544-548.
20. Krueger, A. P., and E. J. Scribner. 1941. The bacteriophage: its nature and its therapeutic use. Journal of the American Medical Association 116:2160-2167, 2269-2277.
21. Lenski, R. E. 1988. Dynamics of interactions between bacteria and virulent phage. Advances in Microbial Ecology 10:1-44.
22. Lenski, R. E., and B. R. Levin. 1985. Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. American Naturalist 125:585-602.
23. Levin, B. R., and J. J. Bull. 1994. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends in Microbiology 2:76-81.
24. Levin, B. R., F. M. Stewart, and L. Chao. 1977. Resource limited growth, competition and predation: a model with some experimental studies with bacteria and bacteriophage. American Naturalist 111:3-24.
25. Lewis, S. 1926. Arrowsmith. Signet Classic, New York.
26. McLean, A. 1993. The balance of power between HIV and the immune system. Trends in Microbiology 1:9-13.
27. Moxon, E. R., P. B. Rainey, M. A. Nowak, and R. E. Lenski. 1994. Adaptive evolution of highly mutable loci in pathogenic bacteria. Current Biology 4:24-33.
28. Neu, H. C. 1992. The crisis in antibiotic resistance. Science (Washington, D.C.) 257:1064-1073.
29. Nowak, M., and R. M. May. 1994. Superinfection and the evolution of virulence. Proceedings of the Royal Society of London B, Biological Sciences 155:81-89.
30. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. W. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science (Washington, D.C.) 245:963-969.
31. Pratt, W. B., and R. Fekerty. 1986. The antimicrobial drugs. Oxford University Press, Oxford.
32. Sakandelidze, V. M. 1991. The combined use of specific phages and antibiotics in different infectious allergoses. Vrachebnoe Delo 3:60-63.
33. Slopek, S., B. Wener-Dabrowska, M. Dabrowoska, and A. Kucharewicz-Krikowska. 1987. Results of bacteriophage treatment of supportive bacterial infections in the years 1981-1986. Archivum Immunologiae et Therapiae Experimentalis 35:569-583.
34. Smith, H. Williams, and M. B. Huggins. 1980. The association of the O18, K1 and H7 antigens and the ColV plasmid of a strain of Escherichia coli with its virulence and immunogenicity. Journal of General Microbiology 121:387-400.
35. _. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Journal of General Microbiology 128:307-318.
36. _. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. Journal of General Microbiology 129:2659-2675.
37. Smith, H. Williams, M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophage. Journal of General Microbiology 133:1111-1126.
38. Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. Journal of Medical Microbiology 37:258-262.
39. Spratt, B. 1994. Resistance to antibiotics mediated by target alternations. Science (Washington, D.C.) 264:388-393.
40. Stone, R. S. 1994. Search for sepsis drugs goes on despite past failures. Science (Washington, D.C.) 264:365-367.
41. Twort, F. W. 1915. An investigation on the nature of the ultra-microscopic viruses. Lancet 2:1241.
42. Whitnack, E. 1993. Sepsis. Pages 770-778 in M. Schaechter, G. Medoff, and B. I. Eisenstein, eds. Mechanisms of microbial disease. 2d ed. Williams & Wilkins, Baltimore.